It appears that the FDA has tenatively approved the extended-release tramadol capsule. Tramadol - also called Ultram - is a non-controlled substance. However, because it is derived from opiates, it has a theoretical potential to cause addictive behavior (well, maybe I shouldn't say it's theoretical since there are clinical studies documenting addiction, abuse, and misuse).
The extended-release tramadol capsule is being developed by Cipher Pharmaceuticals Inc. (not to be confused with the Cypher drug-eluting stent for coronary heart disease)
Post a Comment